期刊文献+

两种抗血小板抗体检测方法的临床应用比较 被引量:3

下载PDF
导出
摘要 血小板抗体(platelet antibody)是由机体免疫调节系统紊乱而产生的一种自身免疫性IgG抗体,它可以引起多种临床疾病或者症状,比如血小板减少症、特发性血小板减少性紫癜(idiopathic throm-bocytopenicpurpura,ITP)、输血后紫癜(post trans-fusion purpura,PTP)、血小板输注无效(refractori-ness to platelet transfusion,RPT)等。
出处 《贵州医药》 CAS 2013年第5期439-441,共3页 Guizhou Medical Journal
基金 贵州省科学技术基金项目 黔科合SY[2010]3129号
  • 相关文献

参考文献11

  • 1Metcalfe P. Platelet antigens and antibody detection [J]. Vox Sanguinis, 2004,87 (1) . 82-86.
  • 2Engelfriet C P, Rtesink H W, Lee K, et al. Detection of plateletrelative antibodies in patients who are refrac- tory to platelet transfusions,and the selection of com- patible donors[-J-]. Vox Sanguinis, 2003,84(1) 73- 78.
  • 3Leimer G C, Stiegler G,Kalhs P, et al. The influence of human platelet antigen match on the success of allo- geneic peripheral blood progenitor cell transplanta.
  • 4Benson K, Fields K, Hiemenz J, et al. The platelet re- fractory bong marrow transplant patient: prophylaxis and treatment of bleeding [J] . Semin Oncon, 1993,20 (5 Suppl 6) . 102-109.
  • 5盛楚华,邱树彬,邱小华.血液病患者血小板输注效果评价及影响因素分析[J].中国全科医学,2006,9(16):1332-1334. 被引量:37
  • 6滕本秀,段前碧,段慧玲,赵敏,李忠俊.输注机采血小板在血液病患者中的效果分析[J].重庆医学,2006,35(11):973-974. 被引量:32
  • 7Schiffer CA. Diagnosis and manfigement of refractori- ness to platelet transfusion[J]. Blood Rev, 2001,15 (4) 175-180.
  • 8Petz L D,Gatty G,Calhoun L,et al. Selecting donors of platelets for refractory patient the basis of HLA an- ti-body specificity [J ]. Transfusion, 2000, 40 ( 12 ) : 1446-1456.
  • 9Levin M D, Kappers-Klunne M,Sintnicolaas K, et al. The value of alloantibody detection in predicting re- sponse to HIA-matched platelet transfusions[J]. Br J Haematol, 2004,124 (2) : 244.
  • 10韩悦,王兆钺,朱明清,王爱青,张威,阮长耿.血小板自身抗体的流式细胞仪检测与意义[J].临床血液学杂志,2000,13(5):222-223. 被引量:25

二级参考文献21

共引文献118

同被引文献46

  • 1刘凌,周旭红,庞缨.不同剂量利妥昔单抗治疗原发性难治性免疫性血小板减少症的临床观察[J].中国生化药物杂志,2014,34(6):126-129. 被引量:15
  • 2孙国栋,段现民,张彦平,尹志柱,牛小利,李艳凤,牛海江,赵有良.献血者血小板1-16抗原基因遗传多态性分析及已知HPA型供者数据库的建立[J].中国实验血液学杂志,2005,13(5):889-895. 被引量:39
  • 3尤建国,李玉峰,汪承亚.血小板输注无效及干预措施的研究进展[J].国际输血及血液学杂志,2006,29(6):499-502. 被引量:28
  • 4Rodeghiero F,Stasi R,Gernsheimer T,et al.Standardization of terminology,definitions and outcome criteria in immune thrombocytopenic purpura of adults and children:report from an international working group[J].Blood,2009,113(11):2386-2393.
  • 5Michel M.Immune thrombocytopenia nomenclature,consensus reports,and guidelines:what are the consequences for daily practice and clinical research?[J].Semin Hematol,2013,50Suppl 1:S50-S54.
  • 6Godeau B.B-cell depletion in immune thrombocytopenia[J].Semin Hematol,2013,50 Suppl 1:S75-S82.
  • 7Cooper N,Bussel JB.The long-term impact of rituximab for childhood immune thrombocytopenia[J].Curr Rheumatol Rep,2010,12(2):94-100.
  • 8Godeau B,Stasi R.Is B-cell depletion still a good strategy for treating immune thrombocytopenia?[J].Presse Med,2014,43(4Pt 2):e79-e85.
  • 9Mahevas M,Patin P,Huetz F,et al.B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells[J].J Clin Invest,2013,123(1):432-442.
  • 10Patel VL,Mahevas M,Lee SY,et al.Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia[J].Blood,2012,119(25):5989-5995.

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部